Cite
Luther JM, Ray J, Wei D, et al. GSK2256294 Decreases sEH (Soluble Epoxide Hydrolase) Activity in Plasma, Muscle, and Adipose and Reduces F2-Isoprostanes but Does Not Alter Insulin Sensitivity in Humans. Hypertension. 2021;78(4):1092-1102doi: 10.1161/HYPERTENSIONAHA.121.17659.
Luther, J. M., Ray, J., Wei, D., Koethe, J. R., Hannah, L., DeMatteo, A., Manning, R., Terker, A. S., Peng, D., Nian, H., Yu, C., Mashayekhi, M., Gamboa, J., & Brown, N. J. (2021). GSK2256294 Decreases sEH (Soluble Epoxide Hydrolase) Activity in Plasma, Muscle, and Adipose and Reduces F2-Isoprostanes but Does Not Alter Insulin Sensitivity in Humans. Hypertension (Dallas, Tex. : 1979), 78(4), 1092-1102. https://doi.org/10.1161/HYPERTENSIONAHA.121.17659
Luther, James M, et al. "GSK2256294 Decreases sEH (Soluble Epoxide Hydrolase) Activity in Plasma, Muscle, and Adipose and Reduces F2-Isoprostanes but Does Not Alter Insulin Sensitivity in Humans." Hypertension (Dallas, Tex. : 1979) vol. 78,4 (2021): 1092-1102. doi: https://doi.org/10.1161/HYPERTENSIONAHA.121.17659
Luther JM, Ray J, Wei D, Koethe JR, Hannah L, DeMatteo A, Manning R, Terker AS, Peng D, Nian H, Yu C, Mashayekhi M, Gamboa J, Brown NJ. GSK2256294 Decreases sEH (Soluble Epoxide Hydrolase) Activity in Plasma, Muscle, and Adipose and Reduces F2-Isoprostanes but Does Not Alter Insulin Sensitivity in Humans. Hypertension. 2021 Sep;78(4):1092-1102. doi: 10.1161/HYPERTENSIONAHA.121.17659. Epub 2021 Aug 30. PMID: 34455816; PMCID: PMC8429121.
Copy
Download .nbib